期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 64, 期 7, 页码 3604-3657出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.1c00208
关键词
-
New drugs introduced to the market are privileged structures with affinities for biological targets implicated in human diseases, providing insights into molecular recognition and guiding future drug design.
New drugs introduced to the market are privileged structures having affinities for biological targets implicated in human diseases and conditions. These new chemical entities (NCEs), particularly small molecules and antibody-drug conjugates, provide insight into molecular recognition and simultaneously function as leads for the design of future medicines. This review is part of a continuing series presenting the most likely process-scale synthetic approaches to 40 NCEs approved for the first time anywhere in the world in 2019.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据